Continuous Infusion of Prostacyclin Normalizes Plasma Markers of Endothelial Cell Injury and Platelet Aggregation in Primary Pulmonary Hypertension
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 • 2,590 citations
Primary Pulmonary Hypertension
1987 • 2,027 citations
Primary Pulmonary Hypertension
1997 • 1,748 citations
An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension
1992 • 1,180 citations
Lung biology in health and disease
1977 • 770 citations
Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin
1994 • 558 citations
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
1987 • 392 citations
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
1987 • 108 citations
Heterogeneity of Pathologic Lesions in Familial Primary Pulmonary Hypertension
1988 • 102 citations
Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients.
1985 • 79 citations
von Willebrand factor abnormalities in primary pulmonary hypertension.
1987 • 72 citations
Vessel injury, platelet adherence, and platelet survival.
1983 • 66 citations
Abnormal Multimeric and Oligomeric Composition Is Associated With Enhanced Endothelial Expression of von Willebrand Factor in Pulmonary Hypertension
1993 • 35 citations
�ber prim�re pulmonale Hypertonie im Kindesalter
1956 • 20 citations